Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Lancet (London, England)
|
November 24, 2004
Military medicine and human rights
Andre N Sofair, Peter G Lurie
JAMA
|
March 18, 2026
Toward Greater Transparency at the FDA-Now Is the Time to Act
Irene Park Ulrich, Peter G Lurie
American Journal of Preventive Medicine
|
February 24, 2019
Harnessing the Power of Food Labels for Public Health
Jennifer L Pomeranz, Peter G Lurie
Foods (Basel, Switzerland)
|
October 26, 2024
Restructuring the FDA's Food Program: Promises and Pitfalls
Sammer Marzouk, Kranti C Rumalla, Peter G Lurie
JAMA Internal Medicine
|
January 27, 2016
Effect of US Drug Enforcement Administration's Rescheduling of Hydrocodone Combination Analgesic Products on Opioid Analgesic Prescribing
Christopher M Jones, Peter G Lurie, Douglas C Throckmorton
The Clinical Journal of Pain
|
August 12, 2016
Trends in the Nonmedical Use of OxyContin, United States, 2006 to 2013
Christopher M Jones, Pradip K Muhuri, Peter G Lurie
American Journal of Public Health
|
February 19, 2016
Increase in Naloxone Prescriptions Dispensed in US Retail Pharmacies Since 2013
Christopher M Jones, Peter G Lurie, Wilson M Compton
JAMA Internal Medicine
|
June 4, 2019
Public Disclosure of the Filing of New Drug and Therapeutic Biologics Applications With the US Food and Drug Administration
Harinder Singh Chahal, David Szeto, Anam H Chaudhry, et al.
BMJ Global Health
|
June 5, 2018
Impact of the US Food and Drug Administration registration of antiretroviral drugs on global access to HIV treatment
Harinder Singh Chahal, Peter Capella, Ryan Presto, et al.
Journal of the International AIDS Society
|
December 13, 2017
The US Food and Drug Administration's tentative approval process and the global fight against HIV
Harinder Singh Chahal, Jeffrey S Murray, Martin Shimer, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Lancet (London, England)
|
November 24, 2004
Military medicine and human rights
Andre N Sofair, Peter G Lurie
JAMA
|
March 18, 2026
Toward Greater Transparency at the FDA-Now Is the Time to Act
Irene Park Ulrich, Peter G Lurie
American Journal of Preventive Medicine
|
February 24, 2019
Harnessing the Power of Food Labels for Public Health
Jennifer L Pomeranz, Peter G Lurie
Foods (Basel, Switzerland)
|
October 26, 2024
Restructuring the FDA's Food Program: Promises and Pitfalls
Sammer Marzouk, Kranti C Rumalla, Peter G Lurie
JAMA Internal Medicine
|
January 27, 2016
Effect of US Drug Enforcement Administration's Rescheduling of Hydrocodone Combination Analgesic Products on Opioid Analgesic Prescribing
Christopher M Jones, Peter G Lurie, Douglas C Throckmorton
The Clinical Journal of Pain
|
August 12, 2016
Trends in the Nonmedical Use of OxyContin, United States, 2006 to 2013
Christopher M Jones, Pradip K Muhuri, Peter G Lurie
American Journal of Public Health
|
February 19, 2016
Increase in Naloxone Prescriptions Dispensed in US Retail Pharmacies Since 2013
Christopher M Jones, Peter G Lurie, Wilson M Compton
JAMA Internal Medicine
|
June 4, 2019
Public Disclosure of the Filing of New Drug and Therapeutic Biologics Applications With the US Food and Drug Administration
Harinder Singh Chahal, David Szeto, Anam H Chaudhry, et al.
BMJ Global Health
|
June 5, 2018
Impact of the US Food and Drug Administration registration of antiretroviral drugs on global access to HIV treatment
Harinder Singh Chahal, Peter Capella, Ryan Presto, et al.
Journal of the International AIDS Society
|
December 13, 2017
The US Food and Drug Administration's tentative approval process and the global fight against HIV
Harinder Singh Chahal, Jeffrey S Murray, Martin Shimer, et al.
Page
of 1